Panico G, Campagna G, Vacca L, Caramazza D, Pizzacalla S, Rumolo V, Scambia G, Ercoli A
Fondazione Policlinico Universitario A. Gemelli IRCCS, UOC Uroginecologia e Chirurgia Ricostruttiva del Pavimento Pelvico, Dipartimento di Scienze della Salute della Donna e del Bambino e di Sanità Pubblica, Roma, Italia,00168.
Università Cattolica del Sacro Cuore, Istituto di Ginecologia ed Ostetricia, Roma, Italia, 00168; 4 PID Ginecologia Oncologica e Chirurgia Ginecologica Miniinvasiva, Università degli studi di Messina, Policlinico G.Martino, Messina, Italia ,98124.
Facts Views Vis Obgyn. 2020 Oct 8;12(3):245-248.
The aim of this case report was to evaluate the feasibility, efficacy, and safety of nerve-sparing laparoscopic sacrocolpopexy (SCP) performed with a minimally invasive approach by using 2.9-mm Senhance ® surgical robotic system (Senhance ® , TRANSENTERIX Inc., USA). A 60-year-old Caucasian woman with symptomatic pelvic organ prolapse-Q (POP-Q) Aa: 2, Ba: 3, C: +4, Bp:2, Ap: 2, TVL:10 underwent subtotal hysterectomy with bilateral salpingo-oophorectomy, with nerve-sparing SCP performed using the Senhance surgical robotic system.. The urogynaecological assessment on the day of discharge and at the 3 month follow-up showed surgical anatomic success (<2 POP-Q stage). The patient was fully satisfied with the cosmetic result. This is the first case of SCP performed with this innovative system. SCP using "Senhance ®" is a feasible and effective approach with good results in terms of operative time, cosmesis, postoperative pain and length of hospitalisation.
本病例报告的目的是评估使用2.9毫米Senhance®手术机器人系统（美国TRANSENTERIX公司的Senhance®）通过微创方法进行保留神经的腹腔镜骶骨阴道固定术（SCP）的可行性、有效性和安全性。一名60岁有症状的盆腔器官脱垂-Q（POP-Q）评分为Aa: 2、Ba: 3、C: +4、Bp:2、Ap: 2、TVL:10的白人女性接受了全子宫切除术加双侧输卵管卵巢切除术，并使用Senhance手术机器人系统进行了保留神经的SCP。出院当天及术后3个月的泌尿妇科评估显示手术解剖成功（POP-Q分期改善<2期）。患者对美容效果非常满意。这是首例使用这种创新系统进行的SCP病例。使用“Senhance®”进行SCP是一种可行且有效的方法，在手术时间、美容效果、术后疼痛和住院时间方面都有良好的结果。
